Abstract
Hepatocellular carcinoma is a heterogeneous disease with considerable differences in malignant behaviour. Some relevant factors for prognosis are known. In this study we analysed DNA ploidy as a potential prognostic parameter. With DNA image cytometry we were able to differentiate between diploid, hypotriploid, triploid, hypertriploid, tetraploid and aneuploid tumours. The best prognosis was for patients with diploid, hypotriploid and tetraploid tumours with a median survival time of 41 months in contrast to 3 months for patients with triploid, hypertriploid or aneuploid tumours. There was a strong correlation between histomorphological parameters and the DNA content. The DNA content of tumour cells may be considerable clinical relevance in hepatocellular carcinoma regarding the decision as to whether or not to perform a resection. In patients with prognostically unfavorable parameters adjuvant oncological therapy may improve the prognosis.
References
Jul 1, 1992·The British Journal of Surgery·N NagasueT Nakamura
Sep 1, 1992·Journal of Hepatology·N NagasueT Nakamura
Aug 1, 1990·Cancer·W M Cong, M C Wu
Feb 15, 1991·Cancer·J FujimotoM Mitsunobu
May 1, 1991·Cancer·T BöttgerT Junginger
Jan 1, 1988·Cancer·T EzakiK Sugimachi
Aug 15, 1988·Cancer·Y YoshidaK Sugimachi
Apr 1, 1986·World Journal of Surgery·H BismuthF Meriggi
Jan 15, 1995·Cancer·S OkadaS Hirohashi
Jul 15, 1994·Cancer·M CottierJ C Audigier
Jul 1, 1994·American Journal of Clinical Pathology·I O NgM K So
Jan 1, 1994·Langenbecks Archiv für Chirurgie·J ZierenJ M Müller
Mar 1, 1994·Annals of Surgery·D G FarmerR W Busuttil
Jan 1, 1994·Cancer·T C BöttgerT Junginger
Jan 1, 1993·Journal of Surgical Oncology. Supplement·K Okuda